Innovative Medical Missions (IMM) is a program designed to address disparities in access to healthcare in the developing world through the use of advanced medical technologies.
The key aspects of this project are:
The creation of a platform for bringing advanced technology.
A novel treatment model for indigent care focused on managing medical missions, designed to train practitioners to coordinate medical missions and continuation of care in high-risk areas with resource-limited and nonexistent healthcare. Over time this will create local teams that are more prepared and responsive to the community needs.
THF partnered with LifeBot to deploy the LifeBot 5, a groundbreaking telemedicine device designed to provide technological support to healthcare teams in the most challenging environments. IMM has received the initial donation from the Mark Paul Terk Charitable Trust of a LifeBot 5.
Innovative Medical Missions’ initiative of The Harris Institute promotes the innovative use of medical technologies in support of philanthropic healthcare missions worldwide.
IMM has partnered with LifeBot and Dr. Brian Scheele of Pacific Northwest Surgical Outreach (PNSO) for the June 2015 inaugural deployment of this device to Belen, Peru, where the LifeBot 5 will support a team of PNSO doctors performing surgical outreach in resource limited communities in the Amazon region. The LifeBot 5 will serve as a link to remote surgical support at the University of Miami (FL) and as an intraoperative anesthesia monitor while in Peru, and IMM will use data collected by the LifeBot 5 to plan and support future missions with the LifeBot 5 and other innovative medical technologies.
Currently the IMM team is in Haiti conducting much needed primary care and disease screening for individuals living in the remote regions of Haiti.